English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 15, 2025

President of Drug Channels Institute: 'Hospital prices are significantly higher at large 340B hospitals'
+ Pharmaceuticals
Patient Daily | Apr 14, 2025

UTHealth Houston unveils new master’s program in cognitive and behavioral sciences
+ Pharmaceuticals
Patient Daily | Apr 14, 2025

Allergists emphasize awareness month for managing allergic asthma in the U.S
+ Pharmaceuticals
Patient Daily | Apr 11, 2025

UTHealth Houston schools rank first in Texas by U.S. News & World Report
+ Pharmaceuticals
Patient Daily | Apr 10, 2025

Researchers uncover mechanisms behind metabolic demands in nursing mothers
+ Pharmaceuticals
Patient Daily | Apr 10, 2025

House budget plan targeting Medicaid, clean air programs faces opposition
+ Pharmaceuticals
Patient Daily | Apr 10, 2025

American Lung Association honors Senator Murkowski and Representative Kelly for lung health advocacy
+ Pharmaceuticals
Patient Daily | Apr 9, 2025

Baylor College of Medicine earns Tier 1 status in U.S. News 2025 rankings

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes